Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: March 4, 2020
Reporting Period: Quarter and year ended December 31, 2019
Context: The filing announces the issuance of a press release containing earnings results and unaudited condensed consolidated financial statements for the periods ended December 31, 2019.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) for detailed financial data. The filing text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
- Revenue: Not provided in filing text.
- Profit: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not contain specific data regarding material changes versus prior comparable periods. Investors must refer to the incorporated press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates by reference a press release containing management commentary and financial data.
Legal Status: The information in Item 2.02 is furnished, not "filed," under the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Emerging Growth Company: The registrant is an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 4, 2020) for specific revenue, net income, and cash flow figures.
- Verify the unaudited condensed consolidated financial statements included in the press release.
- Confirm the impact of the emerging growth company election on financial reporting standards.
- Check for any forward-looking statements or guidance included in the referenced press release.